The global Hormone Replacement Therapy Market Growth Accelerated by Demand For Symptom Relief
Hormone
Replacement Therapy products provide symptom relief from conditions arising due
to hormonal changes associated with menopause, andropause and others. These therapies
help alleviate symptoms such as hot flashes, night sweats, mood swings and
others through administration of hormones like estrogen, progesterone and
testosterone.
The
global Hormone Replacement Therapy Market is estimated to be valued at US$
16460.66 Mn in 2023 and is expected to exhibit a CAGR of 4.7% over the forecast
period 2024 to 2031, as highlighted in a new report published by Coherent
Market Insights.
Market key trends:
One of the key trends driving the growth of the Global Hormone Replacement
Therapy Market Size is the increasing adoption of customized
therapy. With growing awareness, customers are increasingly demanding therapy
customized to their individual needs and symptoms. This has led manufacturers
to offer therapy options which can be customized based on the severity of
symptoms, lifestyle and other factors. Customized therapy enables precise
dosage and type of hormones required by an individual. It has proven to be more
effective in relieving symptoms compared to generic hormone regimens. The
customized therapy trend is expected to continue and drive significant demand
over the forecast period.
Segment Analysis
The global hormone replacement therapy market is segmented into hormone type,
route of administration, application, and distribution channel. Based on
hormone type, the estrogen hormone replacement therapy segment holds the
largest share as estrogen is responsible for development and maintenance of
female sexual characteristics. It reduces the symptoms of menopause, helps
protect bones, and reduces the long-term risks of heart disease, colon cancer,
and Alzheimer's disease.
Key Takeaways
The global hormone replacement therapy market is expected to witness high
growth. The global Hormone Replacement Therapy Market is estimated to be valued
at US$ 16460.66 Mn in 2023 and is expected to exhibit a CAGR of 4.7% over the
forecast period 2024 to 2031.
North
America region currently dominates the hormone replacement therapy market and
is expected to continue its dominance during the forecast period. Due to high
awareness among people about menopause management and treatments. This is
majorly attributed to growing incidence of hormonal disorders and increasing
adoption of hormone replacement therapy drugs in countries like the US and
Canada. According to estimates, around 4.5 million American women undergo
menopause each year.
Key players
Key players operating in the hormone replacement therapy market are
PlayNetwork, Inc., TouchTunes Music Corporation, Sirius XM Holdings, Inc.,
Almotech Media Solutions, Imagesound, Easy on Hold, Soundnet Limited
(Soundjack), Xenox Music & Media B.V., Qsic Pty Ltd., Express Melody,
OpenEar Music, Auracle Sound, Cloud Cover Music, and Mood Media Corporation.
Get More Insights On This Topic: https://www.pressreleasebulletin.com/hormone-replacement-therapy-market-size-share-analysis-2023-2030/
Comments
Post a Comment